Versor Investments LP Collegium Pharmaceutical, Inc Transaction History
Versor Investments LP
- $561 Million
- Q4 2024
A detailed history of Versor Investments LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Versor Investments LP holds 19,582 shares of COLL stock, worth $580,802. This represents 0.1% of its overall portfolio holdings.
Number of Shares
19,582
Previous 14,382
36.16%
Holding current value
$580,802
Previous $555,000
1.08%
% of portfolio
0.1%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding COLL
# of Institutions
245Shares Held
37.2MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$172 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$78.3 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$69.7 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$67.7 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$63.5 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.01B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...